Opella announced on Sunday that the Science Based Targets initiative (SBTi) has officially validated its near- and long-term emissions-reduction goals, confirming that the company’s climate strategy aligns with the Paris Agreement and the global +1.5°C pathway. Under the validated plan, Opella commits to achieving net-zero carbon emissions across its operations and value chain by 2050.
The SBTi—a partnership between CDP, the United Nations Global Compact, the World Resources Institute, and the World Wide Fund for Nature—recognized Opella’s goals as consistent with the Corporate Net-Zero Standard, the world’s first science-based framework for corporate net-zero target setting.
Opella is now the first pure-play global consumer healthcare company to secure both B Corp certification and SBTi-approved net-zero commitments, underscoring its pledge to combine scientific rigor with social and environmental accountability.
Julie Van Ongevalle, Opella President & Chief Executive Officer, said:
“Being both B Corp certified and SBTi validated shows just how committed we are to transforming our business in ways that protect both human and planetary health. I am proud to lead a courageous team driving meaningful change.”
Marissa Saretsky, Chief Sustainability Officer at Opella, commented:
“Science is our compass and data is our roadmap. The SBTi’s validation confirms that our climate strategy is built on evidence and that we are accountable to follow through. Decarbonizing our business is essential for long-term resilience and impact, and we are proud to be part of a global movement turning ambition into action.”
Feirouz Ellouze, Opella AMET General Manager, added:
“We’re turning ambition into action locally and sustainably. Guided by our SBTi-validated targets, we’re empowering healthier lives and a thriving planet across Africa, the Middle East, and Turkey. In Egypt, digitising 60 million paper leaflets could save 5,400 trees and cut 300 tonnes of carbon emissions—a powerful example of how innovation and collaboration can make healthcare more sustainable. Every step forward is a step toward a better tomorrow.”
From a 2023 baseline, Opella has committed to reducing carbon emissions across Scopes 1, 2, and 3 by 58.8% by 2034, and by 90% by 2050. These targets span both operational and value-chain emissions, with priority placed on deep decarbonisation rather than offsetting.
Achieving these goals will require transforming how the company operates, including sourcing low-carbon raw materials, redesigning packaging, transitioning to 100% renewable electricity, and working with suppliers to meet their own science-based targets. Opella will report annually on its progress and review its climate strategy regularly to ensure ongoing alignment with evolving climate science.
